TIANYIN PHARMACEUTICAL CO., INC.: 10-Q filed 2012-05-15

Name: TIANYIN PHARMACEUTICAL CO., INC.: 10-Q filed 2012-05-15
Creator: TIANYIN PHARMACEUTICAL CO., INC.

What TIANYIN PHARMACEUTICAL CO., INC. reported in its quarterly report filed 2012-05-15 (fiscal Q3 2012): 41 published measures, 118 facts as tagged in accession 0001213900-12-002632.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-05-15
Fiscal period: fiscal Q3 2012
Accession: 0001213900-12-002632 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TIANYIN PHARMACEUTICAL CO., INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-03-31	98,878,829	USD
At 2011-06-30	90,201,169	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-03-31	11,172,747	USD
At 2011-06-30	8,921,607	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-03-31	87,121,339	USD
At 2011-06-30	80,844,342	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-03-31	29,860,200	USD
At 2011-06-30	31,724,906	USD
At 2011-03-31	31,066,927	USD
At 2010-06-30	27,009,066	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	893,137	USD	91
2011-07-01 to 2012-03-31	4,155,982	USD	275
2011-01-01 to 2011-03-31	4,061,909	USD	90
2010-07-01 to 2011-03-31	13,422,242	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	4,588,737	USD	275
2010-07-01 to 2011-03-31	12,204,625	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	2,733,195	USD	275
2010-07-01 to 2011-03-31	10,317,824	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	14,358,800	USD	91
2011-07-01 to 2012-03-31	50,124,079	USD	275
2011-01-01 to 2011-03-31	24,880,980	USD	90
2010-07-01 to 2011-03-31	72,165,647	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	-2,748,223	USD	275
2010-07-01 to 2011-03-31	1,146,343	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	-4,790,830	USD	275
2010-07-01 to 2011-03-31	-10,017,524	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-03-31	43,530,000	USD
At 2011-06-30	39,374,018	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	29,294,879	shares	91
2011-07-01 to 2012-03-31	29,300,266	shares	275
2011-01-01 to 2011-03-31	28,218,732	shares	90
2010-07-01 to 2011-03-31	28,031,064	shares	274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	29,294,879	shares	91
2011-07-01 to 2012-03-31	29,300,266	shares	275
2011-01-01 to 2011-03-31	29,822,596	shares	90
2010-07-01 to 2011-03-31	30,062,270	shares	274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	0.03	USD/shares	91
2011-07-01 to 2012-03-31	0.14	USD/shares	275
2011-01-01 to 2011-03-31	0.14	USD/shares	90
2010-07-01 to 2011-03-31	0.47	USD/shares	274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	0.03	USD/shares	91
2011-07-01 to 2012-03-31	0.14	USD/shares	275
2011-01-01 to 2011-03-31	0.14	USD/shares	90
2010-07-01 to 2011-03-31	0.45	USD/shares	274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	368,338	USD	91
2011-07-01 to 2012-03-31	1,543,995	USD	275
2011-01-01 to 2011-03-31	1,323,665	USD	90
2010-07-01 to 2011-03-31	3,171,172	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-03-31	30,171,910	USD
At 2011-06-30	27,465,915	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	39,501	USD	275
2010-07-01 to 2011-03-31	1,913,453	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	1,292,137	USD	91
2011-07-01 to 2012-03-31	5,491,872	USD	275
2011-01-01 to 2011-03-31	5,032,643	USD	90
2010-07-01 to 2011-03-31	14,926,660	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-03-31	50,861,349	USD
At 2011-06-30	47,396,060	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	81,956	USD	91
2011-07-01 to 2012-03-31	214,731	USD	275
2011-01-01 to 2011-03-31	29,791	USD	90
2010-07-01 to 2011-03-31	72,599	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-03-31	11,172,747	USD
At 2011-06-30	8,921,607	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-03-31	10,097,111	USD
At 2011-06-30	9,036,030	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	24,338	USD	275
2010-07-01 to 2011-03-31	0	USD	274

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	3,525,110	USD	91
2011-07-01 to 2012-03-31	11,266,726	USD	275
2011-01-01 to 2011-03-31	5,803,667	USD	90
2010-07-01 to 2011-03-31	18,055,005	USD	274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-03-31	6,298,927	USD
At 2011-06-30	4,932,353	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	4,817,247	USD	91
2011-07-01 to 2012-03-31	16,758,598	USD	275
2011-01-01 to 2011-03-31	10,836,310	USD	90
2010-07-01 to 2011-03-31	32,981,665	USD	274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	9,541,553	USD	91
2011-07-01 to 2012-03-31	33,365,481	USD	275
2011-01-01 to 2011-03-31	14,044,670	USD	90
2010-07-01 to 2011-03-31	39,183,982	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	222,047	USD	91
2011-07-01 to 2012-03-31	643,546	USD	275
2011-01-01 to 2011-03-31	286,020	USD	90
2010-07-01 to 2011-03-31	802,696	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-03-31	29,332,791	shares
At 2011-06-30	29,396,276	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-03-31	30,104,903	USD
At 2011-06-30	30,065,452	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-03-31	8,183,151	USD
At 2011-06-30	6,077,299	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2012-03-31	87,706,082	USD
At 2011-06-30	81,279,562	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-03-31	17,845,570	USD
At 2011-06-30	15,339,194	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	893,114	USD	91
2011-07-01 to 2012-03-31	4,081,901	USD	275
2011-01-01 to 2011-03-31	4,057,417	USD	90
2010-07-01 to 2011-03-31	13,401,121	USD	274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	1,743,384	USD	91
2011-07-01 to 2012-03-31	6,261,834	USD	275
2011-01-01 to 2011-03-31	4,434,803	USD	90
2010-07-01 to 2011-03-31	15,155,596	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	973,947	USD	91
2011-07-01 to 2012-03-31	3,015,108	USD	275
2011-01-01 to 2011-03-31	963,679	USD	90
2010-07-01 to 2011-03-31	4,328,324	USD	274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	851,358	USD	275
2010-07-01 to 2011-03-31	893,896	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-30,685	USD	91
2011-07-01 to 2012-03-31	134,024	USD	275
2011-01-01 to 2011-03-31	348,439	USD	90
2010-07-01 to 2011-03-31	1,645,633	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	868,875	USD	275
2010-07-01 to 2011-03-31	1,235,887	USD	274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	1,240,194	USD	275
2010-07-01 to 2011-03-31	1,682,777	USD	274

Inspect the source

Entity: TIANYIN PHARMACEUTICAL CO., INC. / CIK 0001362718
Captured: 2026-09-22 19:45 UTC
SEC response SHA-256: 906628a22ccc64c913be7c41e1b47cf109b535396d641f5e43d99086a9971e90

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001362718.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))